RNXT RenovoRx, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$1.58
· of 52w range
· above low
· to high
$0.7052w low
$2.5952w high
Market Cap (MRQ)
$71M
P/E (TTM)
-5.1
EPS (TTM)
$-0.31
Revenue (TTM)
$2M
your badges
52W Range
$1–$3
Analyst Rating
BUY
Price Target
$7
P/E
-5.1
ROE
-125.2%
Net Profit Margin
-621.7%
Your badge strip is empty — pin a metric anywhere on this page.
RNXT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.58
Market Cap (MRQ)
$71M
P/E (TTM)
-5.1
EPS (TTM)
$-0.31
Revenue (TTM)
$2M
ROE (TTM)
-125.2%
52W Range
$1–$3
RNXT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$1M2024-12-31 → 2025-12-31
EPS$-0.322022-12-31 → 2025-12-31
Free Cash Flow·2024-12-31 → 2024-12-31
Net margin-621.7%2021-12-31 → 2024-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | RNXT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -5.15Y avg ≈-2.6 | ≈-2.6 | · | · | |
| P/S (TTM) | 36.1 | · | 233.7 | Undervalued | |
| P/B (MRQ) | 7.95Y avg ≈1.3 | ≈1.3 | 2.9 | Overvalued | |
| Price / FCF (TTM) | -6.0 | · | · | · | |
| Price / Cash Flow (TTM) | -6.05Y avg ≈-3.9 | ≈-3.9 | · | · | |
| Price / Tangible Book | 5.75Y avg ≈5.4 | ≈5.4 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | RNXT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 84.4% | · | · | · | |
| Operating Margin (TTM) | -685.2% | · | -2921.7% | Top tier | |
| Net Profit Margin (TTM) | -621.7% | · | -1556.0% | Top tier | |
| ROA (TTM) | -97.8%5Y avg ≈-142.9% | ≈-142.9% | -69.9% | Weak | |
| ROE (TTM) | -125.2%5Y avg ≈88.6% | ≈88.6% | -65.7% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | RNXT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 5.7 | · | 5.7 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | RNXT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 2511.6% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | RNXT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$66.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
2.8%
Next Report
Nov 11, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.05 | $-0.07 | 32.4% |
| March 31, 2026 | May 14, 2026 | $-0.09 | $-0.08 | -10.3% |
| Dec. 31, 2025 | $-0.08 | $-0.08 | 2.0% | |
| Sept. 30, 2025 | $-0.08 | $-0.08 | 2.0% | |
| June 30, 2025 | $-0.08 | $-0.09 | 7.7% | |
| March 31, 2025 | $-0.08 | $-0.08 | 2.0% | |
| Dec. 31, 2024 | $-0.13 | $-0.11 | -15.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $1M | $43.0K | |
| Cost of Revenue | $327.0K | $0 | |
| Gross Profit | $796.0K | $43.0K | |
| R&D Expense | $6M | $6M | |
| SG&A Expense | $7M | $5M | |
| Operating Expenses | $13M | $11M | |
| Operating Income | $-13M | $-11M | |
| Other Non-op | $1M | $2M | |
| Pretax Income | $-11M | $-9M | |
| Income Tax | $2.0K | · | |
| Net Income | $-11M | $-9M | |
| EPS (Basic) | $-0.32 | $-0.40 | |
| EPS (Diluted) | $-0.32 | $-0.40 | |
| Shares (Basic) | 35,333,127 | 22,271,163 | |
| Shares (Diluted) | 35,333,127 | 22,271,163 | |
| EBITDA | · | $-11M |
Balance Sheet
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $7M | $7M | |
| Receivables | $139.0K | $43.0K | |
| Inventory | $189.0K | $0 | |
| Prepaid Expense | $324.0K | $328.0K | |
| Other Current Assets | $217.0K | $303.0K | |
| Current Assets | $8M | $8M | |
| PP&E (Net) | $12.0K | $12.0K | |
| PP&E (Gross) | · | $12.0K | |
| Other Non-current Assets | $0 | · | |
| Total Assets | $8M | $8M | |
| Accounts Payable | $799.0K | $586.0K | |
| Accrued Liabilities | $1M | $1M | |
| Current Liabilities | $2M | $2M | |
| Capital Leases | $107.0K | $212.0K | |
| Total Liabilities | $3M | $4M | |
| Common Stock | $4.0K | $2.0K | |
| Retained Earnings | $-61M | $-50M | |
| Stockholders' Equity | $5M | $4M | |
| Liabilities + Equity | $8M | $8M | |
| Shares Outstanding | 36,613,916 | 24,034,672 |
Cash Flow
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $2M | $0 | |
| Stock-based Comp | $1M | $1M | |
| Deferred Tax | $0 | $0 | |
| Operating Cash Flow | $-11M | $-9M | |
| CapEx | $2.0K | $12.0K | |
| Investing Cash Flow | $-2.0K | $-12.0K | |
| Stock Issued | $12M | $17M | |
| Net Stock Activity | · | $15M | |
| Financing Cash Flow | $11M | $15M | |
| Net Change in Cash | $-130.0K | $6M | |
| Taxes Paid | $1.0K | $2.0K | |
| Free Cash Flow | · | $-9M |
Profitability
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Gross Margin | · | 100.0% | |
| Operating Margin | · | -25511.6% | |
| Net Margin | · | -20497.7% | |
| EBITDA Margin | · | -25511.6% | |
| ROA | · | -183.9% | |
| ROE | · | -152.6% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | · | 4.1 | |
| Quick Ratio | · | 3.8 |
Efficiency
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | · | 0.0 | |
| Receivables Turnover | · | 2.0 |
Per Share
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Book Value / Share | · | $0.19 | |
| Revenue / Share | · | $0.00 | |
| Cash Flow / Share | · | $-0.41 | |
| Cash / Share | · | $0.30 | |
| EPS (TTM) | $-0.32 | $-0.40 |
Growth Rates
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 2511.6% | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $1M | $43.0K | |
| Net Income TTM | $-11M | $-9M | |
| Market Cap | · | $31M | |
| P/E | -2.6 | -3.2 | |
| P/S | · | 721.0 | |
| P/B | · | 6.9 | |
| P / Tangible Book | 5.7 | 6.9 | |
| P / Cash Flow | · | -3.4 | |
| P / FCF | · | -3.4 | |
| Earnings Yield | -38.1% | -31.0% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $909.0K | $563.0K | $238.0K | $266.0K | $422.0K | $197.0K | |
| Cost of Revenue | $143.0K | $84.0K | $28.0K | $53.0K | $152.0K | $94.0K | |
| Gross Profit | $766.0K | $479.0K | $210.0K | $213.0K | $270.0K | $103.0K | |
| R&D Expense | $1M | $1M | $2M | $2M | $1M | $2M | |
| SG&A Expense | $3M | $3M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $4M | $4M | $4M | $3M | $3M | $3M | |
| Operating Income | $-3M | $-3M | $-4M | $-3M | $-3M | $-3M | |
| Other Non-op | $438.0K | $-52.0K | $581.0K | $288.0K | $-217.0K | $690.0K | |
| Income Tax | $0 | $0 | $2.0K | $0 | $0 | $0 | |
| Net Income | $-3M | $-4M | $-3M | $-3M | $-3M | $-2M | |
| EPS (Basic) | $-0.06 | $-0.09 | $-0.08 | $-0.08 | $-0.08 | $-0.08 | |
| EPS (Diluted) | $-0.06 | $-0.09 | $-0.08 | $-0.08 | $-0.08 | $-0.08 | |
| Shares (Basic) | 47,298,148 | 38,032,421 | · | 36,646,278 | 36,576,567 | 31,395,888 | |
| Shares (Diluted) | 47,298,148 | 38,032,421 | · | 36,646,278 | 36,576,567 | 31,395,888 | |
| EBITDA | $-3M | $-3M | · | $-3M | $-3M | $-3M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $12M | $7M | $10M | $12M | $15M | |
| Receivables | $480.0K | $280.0K | $139.0K | $169.0K | $363.0K | $242.0K | |
| Inventory | $383.0K | $379.0K | $189.0K | $272.0K | · | · | |
| Prepaid Expense | $315.0K | $501.0K | $324.0K | $350.0K | $430.0K | $477.0K | |
| Other Current Assets | $153.0K | $198.0K | $217.0K | $145.0K | $288.0K | $444.0K | |
| Current Assets | $11M | $14M | $8M | $11M | $13M | $16M | |
| PP&E (Net) | $94.0K | $77.0K | $12.0K | $13.0K | $13.0K | $13.0K | |
| PP&E (Gross) | · | · | · | $15.0K | · | · | |
| Accum. Depreciation | · | · | · | $2.0K | · | · | |
| Other Non-current Assets | $200.0K | · | · | · | · | · | |
| Total Assets | $11M | $14M | $8M | $11M | $14M | $16M | |
| Accounts Payable | $866.0K | $1M | $799.0K | $869.0K | $671.0K | $967.0K | |
| Accrued Liabilities | $1M | $801.0K | $1M | $1M | $885.0K | $769.0K | |
| Current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | $259.0K | $78.0K | $107.0K | $134.0K | $161.0K | $186.0K | |
| Total Liabilities | $2M | $3M | $3M | $3M | $3M | $3M | |
| Common Stock | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-68M | $-65M | $-61M | $-58M | $-56M | $-53M | |
| Stockholders' Equity | $9M | $11M | $5M | $8M | $11M | $13M | |
| Liabilities + Equity | $11M | $14M | $8M | $11M | $14M | $16M | |
| Shares Outstanding | 45,121,982 | 45,052,706 | 36,613,916 | 36,649,916 | 36,645,884 | 36,546,752 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| D&A | · | $1.0K | $0 | $1M | $1M | · | |
| Stock-based Comp | $570.0K | $317.0K | $285.0K | $349.0K | $345.0K | $288.0K | |
| Operating Cash Flow | $-3M | $-4M | $-3M | $-2M | $-2M | $-3M | |
| CapEx | $71.0K | $0 | $0 | $0 | $0 | $2.0K | |
| Investing Cash Flow | $-71.0K | $0 | $0 | $0 | $0 | $-2.0K | |
| Stock Issued | $0 | $10M | · | · | $0 | $12M | |
| Net Stock Activity | · | $10M | · | · | · | · | |
| Financing Cash Flow | $55.0K | $9M | $0 | $0 | $34.0K | $11M | |
| Net Change in Cash | $-3M | $5M | $-3M | $-2M | $-2M | $7M | |
| Taxes Paid | $1.0K | $0 | $-1.0K | $0 | $1.0K | $1.0K | |
| Free Cash Flow | · | $-4M | · | · | · | $-3M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 84.3% | 85.1% | · | 80.1% | 64.0% | 52.3% | |
| Operating Margin | -368.4% | -616.2% | · | -1203.0% | -634.6% | -1578.7% | |
| Net Margin | -320.2% | -625.4% | · | -1094.7% | -686.0% | -1228.4% | |
| EBITDA Margin | -368.4% | -616.2% | · | -1203.0% | -634.6% | -1578.7% | |
| ROA | -23.2% | -23.5% | · | -27.4% | -22.6% | -23.3% | |
| ROE | -29.7% | -28.8% | · | -38.4% | -29.1% | -32.4% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 7.1 | · | 5.8 | 8.6 | 9.1 | |
| Quick Ratio | 5.3 | 6.6 | · | 5.4 | 8.1 | 8.5 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.7 | 0.4 | · | 0.4 | · | · | |
| Receivables Turnover | 2.2 | 2.2 | · | 3.1 | 2.3 | 1.6 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.20 | $0.25 | · | $0.22 | $0.29 | $0.36 | |
| Revenue / Share | $0.02 | $0.01 | · | $0.01 | $0.01 | $0.01 | |
| Cash Flow / Share | · | $-0.10 | · | · | · | $-0.11 | |
| Cash / Share | $0.21 | $0.27 | · | $0.27 | $0.34 | $0.40 | |
| EPS (TTM) | $-0.31 | $-0.33 | · | $-0.37 | $-0.39 | $-0.41 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $1M | · | · | · | · | |
| Net Income TTM | $-12M | $-12M | · | $-11M | $-11M | $-10M | |
| Market Cap | $44M | $46M | · | $47M | $48M | $36M | |
| P/E | -3.2 | -3.1 | · | -3.4 | -3.4 | -2.4 | |
| P/S | 22.4 | 30.6 | · | · | · | · | |
| P/B | 4.9 | 4.0 | · | 5.8 | 4.5 | 2.8 | |
| P / Tangible Book | 4.9 | 4.0 | · | 5.8 | 4.5 | 2.8 | |
| P / Cash Flow | · | -12.3 | · | · | · | -10.7 | |
| Earnings Yield | -31.6% | -32.7% | · | -29.1% | -29.7% | -41.4% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $1M | $43.0K | · | · | · |
| Gross Margin % | · | 100.0% | · | · | · |
| Operating Margin % | · | -25511.6% | · | · | 680.0% |
| Net Income | $-11M | $-9M | $-10M | $-10M | $-6M |
| Diluted EPS | $-0.32 | $-0.40 | $-0.99 | $-1.09 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | · | 4.1 | · | · | 17.4 |
| Quick Ratio | · | 3.8 | 1.0 | · | 16.2 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $-9M | · | · | · |
Institutional owners (13F) 29 filers · $10.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
29
Value held
$10.3M
New positions
3
Exited positions
6
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 3 (-1 vs prior Q) | 6 (+1 vs prior Q) | 8 (-3 vs prior Q) | 6 (+2 vs prior Q) | +633K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| AIGH Capital Management LLC | $4,317,330 | 4,405,439 | 41.72% | Shares |
| Bleichroeder LP | $1,632,776 | 1,666,098 | 15.78% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,414,867 | 1,443,742 | 13.67% | Shares |
| VANGUARD GROUP INC | $1,348,267 | 1,605,079 | 13.03% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $415,687 | 424,148 | 4.02% | Shares |
| Wealthspire Advisors, LLC | $247,475 | 252,525 | 2.39% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $235,523 | 240,330 | 2.28% | Shares |
| CITADEL ADVISORS LLC | $130,925 | 133,597 | 1.27% | Shares |
| NORTHERN TRUST CORP | $83,503 | 85,207 | 0.81% | Shares |
| Chicago Partners Investment Group LLC | $78,918 | 92,356 | 0.76% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $73,104 | 74,596 | 0.71% | Shares |
| Caprock Group, LLC | $62,661 | 63,940 | 0.61% | Shares |
| JANE STREET GROUP, LLC | $45,471 | 46,399 | 0.44% | Shares |
| Kestra Advisory Services, LLC | $34,810 | 35,520 | 0.34% | Shares |
| TWO SIGMA SECURITIES, LLC | $34,092 | 34,788 | 0.33% | Shares |
| XTX Topco Ltd | $29,383 | 29,983 | 0.28% | Shares |
| Clear Creek Financial Management, LLC | $28,477 | 29,058 | 0.28% | Shares |
| STATE STREET CORP | $25,629 | 26,152 | 0.25% | Shares |
| UBS Group AG | $20,404 | 20,820 | 0.20% | Shares |
| HighTower Advisors, LLC | $19,600 | 20,000 | 0.19% | Shares |
| Cetera Investment Advisers | $18,620 | 19,000 | 0.18% | Shares |
| Affinity Capital Advisors, LLC | $12,583 | 13,279 | 0.12% | Shares |
| CAPTRUST FINANCIAL ADVISORS | $12,061 | 12,307 | 0.12% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $11,172 | 11,400 | 0.11% | Shares |
| MORGAN STANLEY | $6,960 | 7,102 | 0.07% | Shares |
| Midway Capital Research & Management | $6,174 | 6,300 | 0.06% | Shares |
| Tower Research Capital LLC (TRC) | $1,138 | 1,161 | 0.01% | Shares |
| BARCLAYS PLC | $1,128 | 1,151 | 0.01% | Shares |
| SBI Securities Co., Ltd. | $686 | 700 | 0.01% | Shares |
Company insiders 11 insiders · 6 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Shaun Bagai | Chief Executive Officer | April 3, 2026 A | 313,357 | 2 | 0 | $8,750 |
| Mark Voll | Chief Financial Officer | Sept. 10, 2026 A | 222,380 | 1 | 0 | $19,750 |
| Angela Nelms | Chief Operating Officer | Jan. 19, 2024 A | 1,100 | 0 | 0 | $0 |
| Leesa Gentry | Chief Clinical Officer | April 3, 2026 A | · | 0 | 0 | $0 |
| Ramtin Agah | Chief Medical Officer | April 3, 2026 A | 798,460 | 7 | 0 | $55,994 |
| Ron Kocak | VP, Controller and PAO | July 1, 2025 A | 12,595 | 0 | 0 | $0 |
| Kirsten Angela Macfarlane | Director | Oct. 1, 2026 A | 40,983 | 0 | 0 | $0 |
| Laurence Marton | Director | Oct. 1, 2026 A | 9,720 | 0 | 0 | $0 |
| Robert J. Spiegel | Director | Oct. 1, 2026 A | 40,983 | 0 | 0 | $0 |
| Una S Ryan | Director | Oct. 1, 2026 A | 97,165 | 0 | 0 | $0 |
| David Diamond | Director | Oct. 1, 2023 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
RNXT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$5.50
+248.1%
2 20.0%
Strong Buy
7 70.0%
Buy
1 10.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
4 analysts · 2026-09-30Mean target $7.12 +350.9%
← Below all targets
Current price $1.58
Low$3.00
Mean$7.12
High$14.50
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| RNXT | · | -2.6 | 2511.6% | · | · | · |
| GANX | $135M | -5.3 | -60.6% | · | -181.1% | · |
| TENX | $114M | -9.1 | · | · | -52.5% | · |
| ALDX | $312M | -9.2 | · | · | -68.0% | · |
| GRML | · | · | · | · | -104.9% | · |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | · |
| RNTX | · | -0.6 | · | · | · | · |
| IBIO | $97M | -5.5 | -75.0% | -33044.0% | -65.7% | · |
| XBIT | · | -1.6 | · | · | · | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026